Figure 3

CD4 + Decline by Months for Western New York HIV-infected Subjects up to Endpoint (< 500/µL) in HIV-infected Females compared to Males by Hazard Function Model lower women's longevity.
CD4 + Decline by Months for Western New York HIV-infected Subjects up to Endpoint (< 500/µL) in HIV-infected Females compared to Males by Hazard Function Model lower women's longevity.